Skip to main content
. 2014 Oct 1;27(5):329–340. doi: 10.1089/jamp.2013.1099

FIG. 5.

FIG. 5.

Budesonide (a) and formoterol (b) concentrations in plasma (pg/mL) after two inhalations of budesonide/formoterol Easyhaler 320/9 μg/inhalation with concomitant charcoal administration (mean, SE). Treatment A: administration with a 10th percentile target PIF rate; Treatment B: administration with a 4 kPa target PIF rate; Treatment C: administration with subject's maximum PIF rate.